250.100 Source Plasma - Guidelines for Informed Consent
Forms CPG 7134.08
250.500 Plasma Brokers - Registration and Compliance with
Good Manufacturing Practices CPG 7134.22
251.100 Schedule of Physical Examination for Donors
Receiving Immunization Injections CPG 7134.18
252.100 Source Plasma - Regulatory Action Based on
Overbleeding CPG 7134.14
252.110 Volume Limits for Automated Collection of Source
Plasma (03/06/2000 New)
253.100 Use of Units of Plasma and Fresh Frozen Plasma
Which Have Been Thawed CPG 7134.19
254.100 Source Plasma - Use of Units from Donors
Subsequently Found to be Reactive to a Serologic Test for Syphilis CPG 7134.15
255.100 Quantitative Testing for Serum Proteins in
Plasmapheresis Donors CPG 7134.10
256.100 Plasmapheresis - 48-hour Period Between
Plasmapheresis Procedures CPG 7123.23
257.100 Deferral of Source Plasma Donors Due To Red Cell
Loss During Collection of Source Plasma by Automated Plasmapheresis (Reissued, 3/22/2000)
Sub Chapter 270 - 275: Non-blood Products
270.100 Final Container Labels -
Allergenic Extracts Containing Glycerin; Reporting Changes CPG 7134.06
275.100
Immune Milk CPG 7134.04
Sub Chapter 280: In Vitro Diagnostic
Products - Reagents
280.100
Stability Requirements for Licensed In Vitro Diagnostic Products
280.110
Microbiological Control Requirements in Licensed Anti-Human Globulin and Blood Grouping
Reagents
Revised May 31, 2002